Valuation Services

Replicon provides valuation services in traditional industries as well as for high-tech companies. Besides standard free cash flow based valuations our speciality is very indepth Monte Carlo -simulations in drug development projects.

Our valuation related services:

- Fairness opinions in M&A activities and partner screening strategies;
- Assessments on intellectual property;
- Valuations of High-Tech, Biotech and ICT/Mobile companies;and
- Monte Carlo -simulations of eg. drug development projects.

Services provided include the valuation of business enterprises, debt and equity securities, intangible assets, and purchased research & development, as well as the provision of fairness opinions, alternative deal structures and solvency opinions. Our valuations are prepared for a variety of reasons, including mergers and acquisitions, allocation of purchase price, business model development, company re-organization and financing.

On one hand, valuation assignment can be a comprehensive report or plan prepared using and analyzing market trends, company information, assessment of scientific quality, technological leadership, intellectual property status and soft factors such as quality and experience of management and overall company expertise to assess the fair market value of a given company or R&D -project platform. At the same time the report helps to highlight critical factors, which will drive company value in the long term.

On the other hand, assignment can be a monitoring instrument tailored to venture capital funds who wish to have an independent and comprehensive comparative assessment of their portfolio companies. Each company in the fund's portfolio is assessed using different quantitative methodologies and common criteria. This allows funds to monitor portfolio value using a common valuation assessment. Valuation can be effectively employed individually or on an ongoing basis.